Andere Kunden interessierten sich auch für
![Breast Cancer and Antinuclear Antibodies]( "Breast Cancer and Antinuclear Antibodies")
Breast Cancer and Antinuclear Antibodies30,99 €![Current Advances in Breast Cancer Research]( "Current Advances in Breast Cancer Research")
Current Advances in Breast Cancer Research74,99 €![Triumph over Breast Cancer]( "Triumph over Breast Cancer")
Triumph over Breast Cancer17,99 €![PROPHYLACTIC MASTECTOMY IN BREAST CANCER]( "PROPHYLACTIC MASTECTOMY IN BREAST CANCER")
PROPHYLACTIC MASTECTOMY IN BREAST CANCER41,99 €![Breast cancer in young women]( "Breast cancer in young women")
Breast cancer in young women28,99 €![Breast Cancer]( "Breast Cancer")
Breast Cancer28,99 €![Diamonds Pricing and Ethical Issues Surrounding Diamonds]( "Diamonds Pricing and Ethical Issues Surrounding Diamonds")
Diamonds Pricing and Ethical Issues Surrounding Diamonds9,99 €
Genetic screening for breast cancer in at-risk women remains a major ethical issue, given that it rejects controversial images, namely: a frightening image of cancer; a positive image of cancer screening.This system, which is aimed at women aged 50 to 74, invites them to take part in a two-part screening examination every two years: a first reading, a bilateral mammogram in two incidences (face and oblique) analyzed by a radiologist, followed by a second reading if the mammogram is negative. However, new genetic screening techniques for at-risk individuals have revolutionized the way in which breast cancer is now treated at a very early, even preventive, stage. For this reason, the concept remains a controversial one, since in these cases we're not talking about sick people, but healthy people who could potentially become ill in the future. This is why I asked myself the following question: "What is the ethical viewpoint regarding genetic screening for breast cancer in women atrisk, with a view to preventive management?